VIVUS, Inc. (VVUS) Urges Stockholders to Support the Board of Directors and Management Team at This Critical Time
6/17/2013
More...
|
Amicus Therapeutics, Inc. (FOLD) to Host Conference Call Today at 8:00 a.m. ET to Discuss Regulatory Strategy for Migalastat HCl Monotherapy for Fabry Disease
6/17/2013
More...
|
PAREXEL International (PRXL) Invites Public to Listen to Live Webcast of Its Investor Day June 26, 2013
6/17/2013
More...
|
Advaxis, Inc. Announces Voting Results of 2013 Annual Meeting of Stockholders
6/17/2013
More...
|
Mast Therapeutics (MSTX) Prices 50 Million Unit Offering
6/14/2013
More...
|
Abbott Laboratories (ABT) Announces New $3 Billion Share Repurchase Program, Declares Dividend
6/14/2013
More...
|
Royalty Pharma Notes Elan Corporation PLC (ELN) Sales Process Offers Shareholders No Certainty
6/14/2013
More...
|
Biotage AB (BIOTa.ST) - Disclosure Notice of Substantial Holding of Shares
6/14/2013
More...
|
Cempra Pharmaceuticals, Inc. Prices Public Offering of Common Stock
6/14/2013
More...
|
Elan Corporation PLC (ELN) ADS Holders Decisively Vote Against Theravance, Inc. (THRX) And AOP Transactions
6/14/2013
More...
|
Clovis Oncology (CLVS) Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock
6/13/2013
More...
|
Grant of Warrants to an Employee in Genmab A/S (GEN.CO)
6/13/2013
More...
|
Bioniche Life Sciences Inc. (BNC) Founder and CEO Addresses Shareholders
6/13/2013
More...
|
Cempra Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
6/13/2013
More...
|
Elan Corporation PLC (ELN) Boss Martin Faces Ownership Showdown, Elan Risks Losing $2 Billion if Royalty Pharma Walks
6/13/2013
More...
|
Ohr Pharmaceutical (OHRP) to Ring the NASDAQ Stock Market Opening Bell
6/12/2013
More...
|
IRIDEX Corporation (IRIX) Announces Automatic Conversion of Series A Preferred Stock to Common Stock
6/12/2013
More...
|
Ohr Pharmaceutical (OHRP) Announces Approval for Listing on NASDAQ
6/12/2013
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Secures $45 Million Loan Facility
6/12/2013
More...
|
Celgene Corporation (CELG) Announces Additional $3.0 Billion Share Repurchase Program
6/12/2013
More...
|
Clovis Oncology (CLVS) Announces Upsizing and Pricing of Public Offering of Common Stock
6/12/2013
More...
|
Thermo Fisher Scientific (TMO) Announces Exercise of Over-Allotment Option in Common Stock Offering
6/11/2013
More...
|
TNI BioTech Announces Mandatory Exchange of Common Stock Certificates CUSIP Number 872608104 for New Stock Certificates With Active CUSIP 872608203
6/10/2013
More...
|
Advaxis, Inc. Issues Letter Advising Stockholders to Vote FOR Proposals 2 and 3 of Proxy Statement
6/10/2013
More...
|
Clovis Oncology (CLVS) Announces Proposed Offering of Common Stock
6/10/2013
More...
|
Forest Laboratories, Inc. (FRX) Braces for Third Bout With Icahn
6/7/2013
More...
|
Following the Announcement 1 May 2013, H. Lundbeck A/S (LUN.CO) Today Announces the Total Value of the 2013 Long-Term Incentive Programme for Executive Management and Key Employees
6/7/2013
More...
|
XenoPort, Inc. (XNPT) Announces New Employment Inducement Awards
6/7/2013
More...
|
Affymax, Inc. (AFFY) Announces Update on Listing, Senior Leadership and Board Changes
6/7/2013
More...
|
Elan Corporation PLC (ELN)’s Response to Royalty Pharma Announcement
6/7/2013
More...
|
Infinity Pharmaceuticals Inc. (INFI) Tries to Regain Footing After a Rough Session
6/6/2013
More...
|
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program
6/6/2013
More...
|
FEI Company Increases Cash Dividend by 50%
6/6/2013
More...
|
Epizyme (EPZM) Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option
6/6/2013
More...
|
VIVUS, Inc. (VVUS) Files Definitive Proxy Materials With SEC
6/6/2013
More...
|
Advaxis, Inc. Announces Withdrawal of Proxy Statement Proposal to Amend Its Incentive Plan at This Time
6/6/2013
More...
|
Tauriga Sciences Inc. (TAUG) Completes $5 Million Stock Purchase Agreement With New York Based Institutional Investor Magna Group Through Flagship Equity Enhancement Program
6/5/2013
More...
|
Array BioPharma, Inc. (ARRY) Prices Upsized $115 Million Convertible Offering
6/5/2013
More...
|
ARCA biopharma Announces Closing of $20 Million Equity Offering
6/5/2013
More...
|
Fibrocell Science, Inc. CEO Rings the New York Stock Exchange Closing Bell
6/5/2013
More...
|
Theravance, Inc. (THRX) Calls for Redemption of $172.5 Million of 3% Convertible Subordinated Notes Due 2015 (CUSIP No. 88338T AA2)
6/5/2013
More...
|
Kamada Ltd. (KMDA.TA) Announces Closing of Initial Public Offering and Over-Allotment Option Exercise
6/5/2013
More...
|
Z Trim Holdings Reports Continued Sales Growth in May 2013
6/4/2013
More...
|
PDL BioPharma, Inc. (PDLI) Announces Conversion Rate Adjustments for Convertible Notes
6/4/2013
More...
|
Array BioPharma, Inc. (ARRY) Announces Proposed Public Offering of Convertible Debt
6/4/2013
More...
|
StemCells Inc. (STEM) Secures $30 Million Financing Commitment From Lincoln Park Capital
6/4/2013
More...
|
InVivo Therapeutics Corporation (NVIV) Raises $16.1 Million From Warrant Call
6/4/2013
More...
|
Advaxis, Inc. Announces Amendment of Proxy Statement Supplement Further Reduction in Share Capital Proposal
6/4/2013
More...
|
BioTime (BTX) to Raise $9 Million in Registered Direct Offering
6/4/2013
More...
|
Repros Therapeutics Inc. (RPRX) to Webcast Investor and Analyst Day on June 6th
6/3/2013
More...
|
Angiotech Pharmaceuticals, Inc. (ANPI) Announces Return of Capital to Common Shareholders
6/3/2013
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Announces Exercise of Underwriters' Option to Purchase Additional Shares
6/3/2013
More...
|
CorMedix (CRMD) Granted Extension of NYSE MKT Listing
6/3/2013
More...
|
Ohr Pharmaceutical (OHRP) Announces Reverse Split of Common Stock
6/3/2013
More...
|
Biotage AB (BIOTa.ST) – Changes in Number of Shares and Votes
5/31/2013
More...
|
Celsion Corporation (CLN) Announces $9.83 Million Registered Direct Offering
5/31/2013
More...
|
Genmab A/S (GEN.CO) Launches Sponsored Level 1 American Depositary Receipt (ADR) Program
5/31/2013
More...
|
Combined Shareholders’ Meeting of Ipsen (IPN.PA) Held on 31 May 2013
5/31/2013
More...
|
Bioniche Life Sciences Inc. (BNC) Responds to Dissident Shareholders and Rejects Call for Early Shareholder Meeting
5/30/2013
More...
|
Royalty Pharma Recommends Elan Corporation PLC (ELN) Shareholders Vote "NO" On Each of the Elan Resolutions at the Elan Extraordinary General Meeting
5/30/2013
More...
|
Mesa Labs (MLAB) Reports Record Net Income and Revenues
5/30/2013
More...
|
Veloxis Pharmaceuticals A/S (VELO) – Annulment of Warrants and Registration of New Articles of Association Pursuant Thereto
5/30/2013
More...
|
Synergy Pharmaceuticals Added to the MSCI Global Small Cap Indices
5/30/2013
More...
|
ARCA biopharma Announces Pricing of $20 Million Equity Offering
5/30/2013
More...
|
Portola Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Over-Allotment Option Exercise
5/30/2013
More...
|
Bavarian Nordic (BAVA.CO) Establishes a Sponsored Level 1 ADR Program in the U.S.
5/29/2013
More...
|
TG Therapeutics, Inc. (MHA) Approved for Listing on the NASDAQ Capital Market
5/28/2013
More...
|
Elan Corporation PLC (ELN) Announces Pricing of $850 Million in Aggregate Principal Amount of Senior Notes Due 2021
5/24/2013
More...
|
3SBio Inc. (SSRX)'s Shareholders Approve Go-Private Transaction
5/24/2013
More...
|
Jennerex, Inc. Completes $21.6 Million Private Placement
5/23/2013
More...
|
Apricus Biosciences (APRI) Prices $17.1 Million Public Offering of Common Stock and Warrants
5/23/2013
More...
|
Stemline Therapeutics, Inc. (STML) Announces Exercise of Option to Purchase Additional Shares
5/23/2013
More...
|
Zealand Pharma - Announcement of Transactions in the Company’s Shares and Related Securities by Executives and Their Related Parties
5/23/2013
More...
|
Apricus Biosciences (APRI) Announces Proposed Public Offering of Common Stock and Warrants
5/23/2013
More...
|
BioTime (BTX) Announces Results of Vote at Special Meeting of Shareholders
5/23/2013
More...
|
Advaxis, Inc. Announces Filing of Proxy Statement Supplement and New Annual Meeting Date
5/23/2013
More...
|
Portola Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
5/23/2013
More...
|
Merck & Co., Inc. (MRK) Signs $5 Billion Share Buyback Agreement With Goldman, Sachs & Co.
5/22/2013
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Closing of Underwritten Offering
5/22/2013
More...
|
Stemline Therapeutics, Inc. (STML) Announces Closing of $60 Million Public Offering of Common Stock
5/22/2013
More...
|
H. Lundbeck A/S (LUN.CO) – Admittance to Trading and Official Listing of New Shares Due to Exercise of Warrants
5/21/2013
More...
|
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January - March 2013
5/21/2013
More...
|
Royalty Pharma Increases Offer for Elan Corporation PLC (ELN) to $12.50 Per Share in All Cash
5/21/2013
More...
|
Landauer (LDR) Declares Regular Cash Dividend
5/21/2013
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Announces Proposed Public Offering of 6,000,000 Shares of Its Common Stock
5/21/2013
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock
5/21/2013
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5/20/2013
More...
|
Progenics Pharmaceuticals, Inc. (PGNX) Added to the NASDAQ Biotechnology Index
5/20/2013
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Added to NASDAQ Biotechnology Index
5/20/2013
More...
|
CytRx Corporation (CYTR) Issues Letter to Stockholders Providing Business Update
5/20/2013
More...
|
Prima Biomed (PRR.AX) Issues the Following Notice to Stockholders of the Company
5/20/2013
More...
|
Digirad Corporation (DRAD) Rejects Dissident's Call for New Stockholder Meeting as Yet Another Attempt to Seize Control of the Company
5/20/2013
More...
|
TNI BioTech's CEO Issues Letter to Shareholders Discussing Recent Events
5/17/2013
More...
|
Stemline Therapeutics, Inc. (STML) Prices $60 Million Public Offering of Common Stock
5/17/2013
More...
|
Hyperion Therapeutics Added to NASDAQ Biotechnology Index (NBI)
5/17/2013
More...
|
Vertex Pharmaceuticals (MA) (VRTX) Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015
5/17/2013
More...
|
Bristol-Myers Squibb Company (BMY) Announces Intention to Voluntarily Delist Preferred Stock
5/17/2013
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Receives Favorable NASDAQ Listing Decision
5/17/2013
More...
|
PURE Bioscience (PURE) Stock to Begin Trading on the OTCQB Marketplace
5/17/2013
More...
|
Galapagos NV (GLPG.BR) Creates New Warrant Plan
5/17/2013
More...
|
VIVUS, Inc. (VVUS) Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes
5/16/2013
More...
|
Lundbeck Inc. (LUN.CO) Increases its Share Capital by 9,772 Shares (0.005% of Outstanding Shares) as a Result of Employee Warrant Exercise
5/16/2013
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces $20 Million Underwritten Offering
5/16/2013
More...
|
Annual General Meeting of Active Biotech AB (BTPC)
5/16/2013
More...
|
Bavarian Nordic (BAVA.CO) - Interim Financial Report for the Period 1 January to 31 March 2013
5/16/2013
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Proposed Public Offering of Common Stock
5/16/2013
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Receives Favorable NASDAQ Listing Decision
5/16/2013
More...
|
Elan Corporation PLC (ELN) Announces Publication of Response Document
5/16/2013
More...
|
Santarus Inc. (SNTS) Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Secondary Common Stock Offering
5/16/2013
More...
|
Merck & Co., Inc. (MRK) Prices $ 6.5 Billion Debt Offering
5/16/2013
More...
|
Rockwell Medical Technologies (RMTI) Prices $35.0 Million Public Offering of Common Stock
5/15/2013
More...
|
VIVUS, Inc. (VVUS) Announces Proposed Offering of Convertible Senior Notes
5/15/2013
More...
|
Discovery Laboratories (DSCO) Announces Completion of $14.25 Million Public Offering
5/15/2013
More...
|
Fibrocell Science, Inc. Announces Approval of Common Stock Listing on NYSE MKT
5/15/2013
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Prices Public Offering of Common Stock
5/15/2013
More...
|
Sucampo Pharmaceuticals, Inc. (SCMP) to be Added to the NASDAQ Biotechnology Index
5/15/2013
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Proposed Public Offering of Common Stock
5/15/2013
More...
|
BioAmber Inc. Announces Closing of Initial Public Offering
5/15/2013
More...
|
TopoTarget A/S Release: Shareholder Meetings in Copenhagen and Aarhus
5/14/2013
More...
|
Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index
5/14/2013
More...
|
RegeneRx Biopharmaceuticals, Inc. (RGRX) Issues Letter to Sharholders
5/14/2013
More...
|
Omeros Corporation (OMER) Announces Closing of $16.2 Million Registered Direct Offering of Common Stock
5/14/2013
More...
|
SIGA Technologies, Inc. (SIGA) Announces Restatement of Certain Historical Financial Results to Reflect Reclassification of Warrants as a Liability
5/13/2013
More...
|
Warner Chilcott, PLC (WCRX) Release: Announcement Under Irish Takeover Rules Relevant Securities in Issue
5/13/2013
More...
|
Discovery Laboratories (DSCO) Announces Proposed Public Offering of Common Stock
5/10/2013
More...
|
Omeros Corporation (OMER) Announces $16.2 Million Registered Direct Offering of Common Stock
5/10/2013
More...
|
Pain Therapeutics (PTIE) Files Form 8-K Regarding Correspondence From Pfizer Inc. (PFE)
5/10/2013
More...
|
BioAmber Inc. Announces Pricing of Initial Public Offering
5/10/2013
More...
|
Karolinska Development AB - Interim Report January - March 2013
5/10/2013
More...
|
NeoStem, Inc. Clarification: No New Securities Being Issued
5/10/2013
More...
|
Santarus Inc. (SNTS) Announces Launch of a Proposed Secondary Common Stock Offering by a Selling Stockholder
5/10/2013
More...
|
Aceto Corporation Board of Directors Declares Quarterly Cash Dividend
5/10/2013
More...
|
NeoStem, Inc. CEO's Letter to Shareholders
5/10/2013
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Announces 20:1 Reverse Stock Split Effective After Market Close on May 10th
5/10/2013
More...
|
Santarus Inc. (SNTS) Announces Pricing of Secondary Common Stock Offering by a Selling Stockholder
5/10/2013
More...
|
Immunotech Laboratories Corporate Shareholder Update Summary
5/9/2013
More...
|
AEterna Zentaris (AEZS) Announces Election of Directors at Its Annual Meeting of Shareholders
5/9/2013
More...
|
MethylGene Announces Plan to Reincorporate in the United States as Mirati Therapeutics, Inc. and List on the NASDAQ
5/9/2013
More...
|
Receptos Announces Pricing of Initial Public Offering of Common Stock
5/9/2013
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) and ANI Pharmaceuticals, Inc. Announce Special Meetings of Stockholders to Consider Proposed Merger
5/9/2013
More...
|
Sonomax Technologies Announces Listing on the CNSX
5/9/2013
More...
|
IntelGenx Corp. Security Holders Approved the Amendment of the 2006 Stock Option Plan
5/9/2013
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Prices Public Offering of Common Stock
5/9/2013
More...
|
Zealand Pharma Announces Amendments to its Articles of Association
5/8/2013
More...
|
Notice of Zealand Pharma ’s Interim Report for Q1 2013
5/8/2013
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Announces Proposed Public Offering of Common Stock
5/8/2013
More...
|
Bayer HealthCare (BAY) Commences Cash Tender Offer for All Outstanding Shares of Conceptus, Inc. (CPTS)
5/8/2013
More...
|
Sigma-Aldrich Corporation (SIAL) Declares $0.215 Per Share Quarterly Dividend
5/8/2013
More...
|
GW Pharmaceuticals Announces the Closing of Its Initial Public Offering on the Nasdaq Global Market
5/8/2013
More...
|
Warner Chilcott, PLC (WCRX) Declares Semi-Annual Cash Dividend of $0.25 Per Share
5/8/2013
More...
|
DiaGenic ASA: Increase in Share Capital
5/8/2013
More...
|
Idera Pharmaceuticals, Inc. (IDRA) Announces Closing of Common Share Offering
5/8/2013
More...
|
Nuvo Research Inc. (NRI.TO) to Complete Share Consolidation
5/7/2013
More...
|
Karolinska Development AB - Interim Report January - March, Invitation to Conference Call Friday, May 10
5/7/2013
More...
|
INSYS Therapeutics Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option
5/7/2013
More...
|
Lignol Provides Addional Funding to Territory Biofuels Limited to Obtain Fully Diluted Majority Interest
5/6/2013
More...
|
Change in the Number of Votes Relating to BioTie Therapies Corp.'s Shares
5/6/2013
More...
|
PledPharma Appoints Advisor for the Commercialization of PledOx®
5/6/2013
More...
|
Novo Nordisk A/S (NVO) - Share Repurchase Program
5/6/2013
More...
|
Adamis Pharmaceuticals CEO Provides Update for Shareholders
5/6/2013
More...
|
3SBio Inc. (SSRX) Schedules Take-Private Vote for May 24
5/3/2013
More...
|
LipoScience, Inc. to Release First Quarter Fiscal Year 2013 Financial Results
5/3/2013
More...
|
Myriad Genetics, Inc. (MYGN) Announces 2013 Analyst and Investor Day
5/3/2013
More...
|
Kythera Biopharmaceuticals to Release First Quarter 2013 Operating Results
5/3/2013
More...
|
ChemoCentryx, Inc. (CCXI) to Hold First Quarter 2013 Financial Results Conference Call on Monday, May 13, 2013
5/3/2013
More...
|
PRANA Biotechnology (PRAN) Announces Share Purchase Plan Closed
5/3/2013
More...
|
Sanofi (France) (SAN.PA): Q1 2013 Business EPS(1) Impacted by Exclusivity Losses in Prior Year
5/2/2013
More...
|
3SBio Inc. (SSRX) Files Annual Report on Form 20-F for Fiscal Year 2012
5/2/2013
More...
|
Merck & Co., Inc. (MRK) Sales Disappoint; Company Cuts Profit Outlook
5/1/2013
More...
|
Sinovac Biotech Ltd. (SVA) Files Annual Report on Form 20-F
5/1/2013
More...
|
DW Healthcare Partners Invests in Med-Pharmex, Inc.
5/1/2013
More...
|
Stock House Group Report Initiates Coverage on Plandai Biotechnology, Inc. (PLPL.OB)
5/1/2013
More...
|
Coronado Biosciences to Report First Quarter 2013 Financial Results
5/1/2013
More...
|
Polydex Pharmaceuticals (POLXF) Reports Strong Backlog Resulting From Worldwide Increase in Demand for Product in 2013 Fiscal Year End Financial Results
5/1/2013
More...
|
NeoStem, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option
5/1/2013
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Reports First Quarter 2013 Financial Results
5/1/2013
More...
|
Mela Sciences (MELA) Announces First Quarter 2013 Financial Results
5/1/2013
More...
|
Amyris, Inc. Reports First Quarter 2013 Financial Results
5/1/2013
More...
|
Chrontech Pharma AB Receives Extended Offer From a Group of Shareholder
4/30/2013
More...
|
NYSE Liffe Lists Equity Options on Galapagos NV (GLPG.BR)
4/30/2013
More...
|
Novo Nordisk A/S (NVO) - Share Repurchase Program
4/30/2013
More...
|
Total Number of Voting Rights and Share Capital in Novo Nordisk A/S (NVO) as of 30 April 2013
4/30/2013
More...
|
Techne Corp. (TECH) Declares Dividend
4/30/2013
More...
|
Merrimack Pharmaceuticals Inc. Announces Timing of First Quarter 2013 Investor Conference Call
4/30/2013
More...
|
Momenta Pharmaceuticals, Inc. (MNTA) Reports First Quarter 2013 Financial Results
4/30/2013
More...
|
Cleveland Biolabs Inc. (CBLI) to Report First Quarter 2013 Financial Results and Provide Operational Update on May 9
4/30/2013
More...
|
Medical Marijuana, Inc. Shareholder Update and Letter
4/30/2013
More...
|
Aegerion Pharmaceuticals, Inc. (AEGR) Announces First-Quarter 2013 Financial Results
4/30/2013
More...
|
Bioniche Life Sciences Inc. (BNC) Acknowledges Request for Shareholder Meeting
4/29/2013
More...
|
GENFIT Corp. (ALGFT): Conversions Into Shares of 30 Bonds OCA2012-2
4/29/2013
More...
|
iBio, Inc. (IBIO) Closes $4.2 Million Public Offering and Terminates at-the-Market Offering
4/29/2013
More...
|
Neovasc Inc. (NVC) Reports Financial Results for 2012 Year-End
4/29/2013
More...
|
Galapagos NV (GLPG.BR) Completes Private Placement by Issuance of 2,696,831 New Ordinary Shares
4/29/2013
More...
|
Digirad Corporation (DRAD) Urges Stockholders to Vote the WHITE Proxy Card to Support Digirad's Director Nominees
4/26/2013
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Prices $20 Million Public Offering of Common Stock
4/26/2013
More...
|
Biotage AB (BIOTa.ST) Launches Share Buy-Back
4/26/2013
More...
|
Supernus Pharmaceuticals (SUPN) Prices Offering of $75 Million of 7.50% Convertible Senior Secured Notes Due 2019
4/26/2013
More...
|
PURE Bioscience (PURE) Receives Favorable NASDAQ Listing Decision
4/25/2013
More...
|
Nuvilex Price Valuation Justifies Investors' Confidence in Biotech
4/25/2013
More...
|
3SBio Inc. (SSRX) Adjourns Extraordinary General Meeting of Shareholders
4/25/2013
More...
|